Atrovent and Skin hypertrophy - a phase IV clinical study of FDA data

Summary:

Skin hypertrophy is reported as a side effect among people who take Atrovent (ipratropium bromide), especially for people who are male, 60+ old, also take Magnevist, and have Anaemia.

The phase IV clinical study analyzes which people have Skin hypertrophy when taking Atrovent. It is created by eHealthMe based on reports of 33,026 people who have side effects when taking Atrovent from the FDA, and is updated regularly.

What is Atrovent?

Atrovent has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 33,210 Atrovent users. Check the latest studies of Atrovent.

What is Skin hypertrophy?

Skin hypertrophy (skin cells enlarges) is found to be associated with 588 drugs and 546 conditions by eHealthMe. Check the latest studies of Skin hypertrophy.

On Aug, 02, 2026

33,026 people reported to have side effects when taking Atrovent.
Among them, 41 people (0.12%) have Skin hypertrophy.

Among these 41 people:

What is the gender of people who have Skin hypertrophy when taking Atrovent? *

female: 47.5 %
male: 52.5 %

What is the age of people who have Skin hypertrophy when taking Atrovent? *

What are other drugs people take besides Atrovent? *

What are other side effects people have besides Skin hypertrophy? *

Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 38 people, 92.68%
Oedema Peripheral (superficial swelling): 36 people, 87.80%
Skin Tightness: 36 people, 87.80%
Pain: 34 people, 82.93%
Joint Range Of Motion Decreased (disease of joint movement): 31 people, 75.61%
Skin Induration (an abnormally hard spot or area on the skin): 30 people, 73.17%
Itching: 27 people, 65.85%
Stress And Anxiety: 27 people, 65.85%
Mobility Decreased (ability to move is reduced): 24 people, 58.54%
Joint Contracture (a permanent shortening of a muscle or joint): 23 people, 56.10%

What are the existing conditions these people have? *

Anaemia (lack of blood): 13 people, 31.71%
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 9 people, 21.95%
Polymyalgia Rheumatica (pain in many muscles): 9 people, 21.95%
Depression: 9 people, 21.95%
Nuclear Magnetic Resonance Imaging Brain: 8 people, 19.51%
Diabetes: 5 people, 12.20%
Gout (uric acid crystals building up in the body): 4 people, 9.76%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 9.76%
Rash Pruritic (redness with itching): 3 people, 7.32%
Upper Respiratory Tract Infection: 2 people, 4.88%

* Approximation only. Some reports may have incomplete information.

Do you take Atrovent and have Skin hypertrophy?

- Check whether Skin hypertrophy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atrovent:

Atrovent (33,210 reports)

Browse all side effects of Atrovent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin hypertrophy:

Skin hypertrophy (588 drugs)

Browse all the conditions that are associated with Skin hypertrophy:

Skin hypertrophy (546 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ipratropium bromide (the active ingredients of Atrovent) and Atrovent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.